Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

ConclusionSignificant gains in cost efficiency can be realized for a decision maker using a CO model, especially for a disease like influenza with many vaccine options. Testing the model under different scenarios offers powerful insights into maximum achievable benefit overall and per age group within the predefined constraints of a vaccine budget.

http://link.springer.com/10.1007/s40258-019-00534-y

Source: Applied Health Economics and Health Policy - November 21, 2019 Category: Health Management Source Type: research